From data overload to decision clarity in drug discovery

Are you bogged down by endless Excel files and fragmented lab data? Struggling with tools that slow down discovery rather than speed it up?

Imagine if your data worked for you. Clear, ready-to-use insights to guide each step of your drug discovery process.

No more waiting on bioinformatics reports or wrestling with complex files. Your data should accelerate breakthroughs, not hold them back.

 

What you’ll learn:

Available tools landscape
  • Learn how your research team can focus on drug development using high quality AI and data tools.
  • You can address 10x more of your scientific questions with 10x less experiments, by expanding your toolkit with AI-driven and computational analytics
Data Ingestion and Management
  • Understand how the variety of externally available and your in-house data sources can work together to generate insights.
  • You can reduce the the cost-per-use of your data by enabling its use across multiple projects with FAIR principles.
Real life Use Cases
  • Experience how companies from small biotech to big pharmas can cut the data struggle with a proper toolkit.
  • You can focus on breaking new scientific ground while we manage and optimize your developments, ensuring nothing is left behind.

Meet our speakers:

Jan Majta

Tribe Leader, Senior Bioinformatician

Jan took part in over 50 projects for companies from biotech start-ups up to top pharma players, leading teams of bioinformaticians, software engineers and AI developers.

Using his background in both biotechnology and bioinformatics his focus is on providing the most suitable solution for Aridgen’s customers aiding their drug discovery and development processes. 

Błażej Szczerba

Associate Director of Software Engineering

Błażej Szczerba joined Ardigen in 2019 and has since focused on bridging the gap between software engineering and life sciences. His focus is on creating bioinformatics workflows, data pipelines, and data management systems tailored to both clinical and research environments.

He has successfully led multiple projects aimed at optimizing data processing and analysis, ensuring that the software solutions effectively address the specific needs of the biotech and pharmaceutical sectors.

You might be also interested in:

Accelerating biomarker discovery through omic data integration into drug screens
Accelerating biomarker discovery through omic data integration
Two scientists observing AI-driven cell analysis on a digital screen, representing decision-making in biotech innovation.
Build or Buy? Strategic Considerations for Biotech Companies Implementing AI Solutions
biotech US market
AI in biotech: What the US market got right (and what it’s still learning)
From Data Chaos to Drug Discovery – Ardigen Talk at NextGen Omics Conference

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!